What the KRW 46.7 Trillion Figure Revealed About June’s Market: A Handful of Mega-Deals Beat Deal Volume

In Korea’s M&A and investment market in June 2026, 88 deals were logged, but the real center of gravity was concentrated in 11 mega-deals worth more than KRW 1 trillion each, totaling KRW 42.3 trillion.

After removing duplicates, there were 88 deals in total: 30 with disclosed values and 58 undisclosed. The combined disclosed value came to KRW 46.7 trillion, with an average of KRW 1.6 trillion. At a glance, the numbers make the market look broadly distributed, but a closer look tells a different story. The 11 large deals above KRW 1 trillion accounted for the vast majority of disclosed value, while the rest—mid-sized, small, and micro deals—were effectively just filling out the base in value terms. There were plenty of deals, but only a handful captured the money. June was exactly that kind of month.

At a Glance

Total Deals	Disclosed Value	Total Deal Value	Average Deal Value
88 deals	30 deals	KRW 46.7 trillion	KRW 1.6 trillion

A month shaped by 11 deals worth over KRW 1 trillion, while the rest mostly focused on strategic reinforcement

The large-deal segment saw 11 transactions totaling KRW 42.3 trillion, with an average deal size of KRW 3.8 trillion. The headline deal was Merck’s acquisition of Bio-Techne, and the key sectors in play were biotech and semiconductors. In other words, June’s big-ticket deals were less about spreading across the full range of cyclical industries and more about money betting on technology, growth, and industries with long value chains. By contrast, the mid-sized segment recorded 12 deals worth KRW 4.1 trillion in total, averaging KRW 344.7 billion, with biotech and real estate contributing two deals each. The standout deal here was SK Telecom and SK hynix investing in a U.S. AI investment vehicle. Put simply, trillion-won deals were about changing control and reshaping the board itself, while mid-sized deals were about reinforcing specific themes.

The small and micro segments were even more telling. The KRW 50 billion to KRW 100 billion range had exactly one deal, worth KRW 95 billion, represented by POSCO Holdings’ acquisition of a 30% stake in a U.S. rare-earth permanent magnet company. The micro segment logged six deals totaling KRW 117.5 billion, with an average of KRW 19.6 billion, and future-facing themes such as space, aerospace, and batteries stood out. Hancom’s sale of a 26.08% stake in Hancom InSpace also falls into this category. Small in size, but clear in direction. It wasn’t just about blockbuster takeover battles; the market also kept seeing smaller transactions that either added supply-chain and new-business options or cleaned them up. Big money was concentrated in a handful of deals, while smaller money went into portfolio adjustments. Doesn’t that tell you the market was being cautious?

Segment	Count	Total Deal Value	Average	Key Industries	Representative Deal
Large (KRW 1tn+)	11	KRW 42.3tn	KRW 3.8tn	Biotech (1), Semiconductors (1)	Merck acquisition of Bio-Techne
Mid-sized (KRW 100bn–1tn)	12	KRW 4.1tn	KRW 344.7bn	Biotech (2), Real Estate (2)	SK Telecom and SK hynix investment in a U.S. AI investment vehicle
Small (KRW 50bn–100bn)	1	KRW 95bn	KRW 95bn	Secondary Batteries & Materials (1)	POSCO Holdings acquisition of a 30% stake in a U.S. rare-earth permanent magnet company
Micro (Below KRW 50bn)	6	KRW 117.5bn	KRW 19.6bn	Space & Aerospace (1), Batteries (1)	Hancom sale of a 26.08% stake in Hancom InSpace
Undisclosed	58	—	—	—	—

Finance led with six deals, but biotech and AI set the market’s pulse racing

Finance ranked No. 1 by count with six deals, but the sectors that really defined the market’s presence were biotech with five, AI with two, and a large deal tied to semiconductors.

Finance topped the list with six deals, followed by biotech with five, real estate with four, retail with three, defense with two, medical devices with two, AI with two, and pharma/bio with two. But deal count and market impact are not the same thing. Finance is naturally a sector where deal volume piles up easily because transaction structures are so varied, and real estate also kept showing up repeatedly in the mid-sized range. By contrast, what really captured the market’s attention was biotech and AI. With large-cap biotech, mid-cap biotech, and even capital contributions to the U.S. AI investment vehicle of SK Telecom and SK hynix all lining up, it is more accurate to say that June drew more spotlight to “technology positioning” than to “defending cash flow.”

The two defense deals and two medical device deals are not numbers to gloss over either. If the market were focused only on traditional manufacturing, this kind of mix would have been hard to produce. The three retail deals carry the scent of restructuring and portfolio reshuffling, while the four real estate deals signal that asset transactions are still holding up. In the end, June’s industry mix reads as a month when both safe-haven assets and growth assets changed hands, but the symbolism and buzz around the money clearly belonged to the growth sectors.

Industry	Number of Deals
Finance	6
Biotech	5
Real Estate	4
Retail	3
Defense	2
Medical Devices	2
AI	2
Pharma/Bio	2

What Merck·Bio-Techne and SK Telecom·SK hynix Showed: The Difference Between Reshuffling the Board and Laying the Groundwork

Put the marquee large-cap deals next to the representative mid-cap ones, and the contrast in texture becomes obvious. Merck’s acquisition of Bio-Techne was a deal that symbolized the large-cap bracket, while SK Telecom’s capital contribution to SK hynix’s U.S. AI investment vehicle pointed to where the mid-cap bracket is headed. The former is a transaction on a scale that can reshape an industry landscape; the latter is closer to staking out a position for the next cycle. Both lean on technology and future growth, but the way capital was deployed was completely different.

Deal	Acquirer → Target	Amount	Industry	Type	Status
Merck acquires Bio-Techne	Merck → Bio-Techne	KRW 15.6 trillion	Bio	M&A	Signed
onsemi acquires Synaptics	onsemi → Synaptics	KRW 8.6 trillion	Semiconductors	M&A	Signed
Sale of SK Siltron	- → SK Siltron	KRW 5.0 trillion	Semiconductor materials	Sale	In negotiations
Salesforce acquires Fin	Salesforce → Fin	KRW 5.0 trillion	Software	M&A	Signed
Global Sae-A pushes bundled sale of Tailim Packaging and Jeonju Paper	- → Tailim Packaging·Jeonju Paper	KRW 2.0 trillion	Paper·Packaging	Sale	Under review
SK Gas sells minority stake in Ulsan GPS	- → Ulsan GPS	KRW 1.2 trillion	Energy	Sale	Signed
Korea Investment Partners PE Division acquires MNC Solution	Korea Investment Partners PE Division → MNC Solution	KRW 1.0 trillion	Defense	PE investment	In negotiations
National Growth Fund·Advanced Strategic Industry Fund invest about KRW 1 trillion in LigaChem Bio and LIG D&A	National Growth Fund·Advanced Strategic Industry Fund·private financial institutions → LigaChem Bio, LIG D&A	KRW 1.0 trillion	Bio·Defense	Equity investment	Signed
KL&Partners sells Mom’s Touch	- → Mom’s Touch	KRW 1.0 trillion	Dining/Franchise	Sale	In negotiations
Samsung SRA Asset Management pushes sale of The K Twin Towers	- → The K Twin Towers	KRW 1.0 trillion	Real estate	Sale	In negotiations
ContentreeJoongAng pushes sale of SLL JoongAng	- → SLL JoongAng	KRW 1.0 trillion	Media·Content	Sale	In negotiations
SK Telecom capital contribution to SK hynix’s U.S. AI investment vehicle	SK Telecom → SK hynix U.S. AI investment vehicle	KRW 738.3 billion	AI	Equity investment	Signed
IMM Private Equity acquires 51% stake in CG Bio	IMM Private Equity → CG Bio	KRW 561.0 billion	Medical devices	PE investment	In negotiations
EQT Partners acquires Remember & Company	EQT Partners → Remember & Company	KRW 500.0 billion	HR tech	PE investment	Completed
Project fund invests KRW 500.0 billion in LIG D&A preferred shares	Advanced Strategic Industry Fund·private financial institutions project fund → LIG D&A	KRW 500.0 billion	Defense industry	Equity investment	Under review
SBI Holdings acquires bitbank	SBI Holdings → bitbank	KRW 447.0 billion	Digital assets	M&A	In negotiations
IMM Asset Management·TKG Huchems acquire control of AprilBio	IMM Asset Management·TKG Huchems → AprilBio	KRW 346.8 billion	Bio	M&A	Signed
Hanwha Corp. sells Pangyo Future Technology Research Center	- → Pangyo Future Technology Research Center	KRW 300.0 billion	Real estate·Corporate assets	Sale	Signed
Foreign corporation pushes sale of Ireland Castle	Foreign corporation → Ireland Castle	KRW 200.0 billion	Real estate	Sale	In negotiations
Kakao Pay acquires remaining stake in Kakao Pay Securities	Kakao Pay → Kakao Pay Securities	KRW 173.0 billion	Finance	Equity investment	Signed
Samsung invests in Grail	Samsung affiliates including Samsung C&T → Grail	KRW 151.0 billion	Bio	Equity investment	Completed
Ajeongdang-linked buyer acquires Diad Cheongdam	Newly wealthy buyer linked to Ajeongdang → Diad Cheongdam	KRW 112.1 billion	Real estate	M&A	Completed
Kyobo Life acquires remaining stake in Kyobo AXA Investment Managers	Kyobo Life → Kyobo AXA Investment Managers	KRW 107.5 billion	Finance	M&A	Signed

The Tangible Realism of Small Deals Seen in POSCO’s 30% and Hancom’s 26.08%

Small and micro deals may be modest in size, but they spoke in a far more grounded strategic language.

POSCO Holdings’ acquisition of a 30% stake in a U.S. rare-earth permanent magnet company was the sole deal in the small-deal bracket at KRW 95 billion, and it was a transaction whose message outweighed its size. The purpose was highly specific: securing supply chains and materials. The same goes for the micro-deal segment that included Hancom’s sale of a 26.08% stake in Hancom InSpace. Six deals, KRW 117.5 billion in total, KRW 19.6 billion on average. On paper, the numbers look minor, but in practice this is where business restructuring, cash 확보, and sharper focus on core priorities came through more clearly. While megadeals grabbed the headlines, the more practical decision-making was actually more visible here.

Deal	Acquirer → Target	Amount	Industry	Type	Status
POSCO Holdings acquires a 30% stake in a U.S. rare-earth permanent magnet company	POSCO Holdings → U.S. rare-earth permanent magnet company	KRW 95 billion	Secondary batteries · Materials	Equity investment	Contract signed
Hancom sells a 26.08% stake in Hancom InSpace	- → 26.08% stake in Hancom InSpace	KRW 31.9 billion	Space · Aerospace	Sale	Completed
Samsung SDI invests in Forge Nano	Samsung SDI → Forge Nano	KRW 30 billion	Battery	Equity investment	Contract signed
KakaoBank acquires Marston Capital	KakaoBank → Marston Capital	KRW 24.1 billion	Finance	M&A	Contract signed
KS Industry acquires Inscobee CBs	KS Industry → Inscobee	KRW 20 billion	Financial investment	Equity investment	Under negotiation
PH Korea acquires Pizza Hut Korea	PH Korea (joint venture of K Clavis Investment and Wintergold PE) → Pizza Hut Korea	KRW 11 billion	Dining · Franchise	M&A	Completed
Han Sang-cheol purchases a stake in Jeil Pharma Holdings	Han Sang-cheol → Jeil Pharma Holdings	KRW 500 million	Pharmaceuticals	Equity investment	Completed

24 Deals Under Review and 21 in Negotiation Are the Homework Carried Into July

The key next month is not how many new deals emerge, but how many of the 24 under review and 21 in negotiation actually move into signing and closing.

June’s breakdown by status is fairly balanced: 24 under review, 22 signed, 21 in negotiation, and 21 closed. Quite a few deals have already been signed and completed, but it also means there is still a sizable pipeline hovering just short of a decision. If this segment starts moving in July, total deal value could jump again even if the deal count does not. Especially in a market structure like June’s, where a handful of large deals determine the overall value, progress on just one or two transactions can completely change the monthly picture.

Another point to watch is the divergence in momentum across industries. Will finance and real estate continue to pile up deal count, or will growth sectors like biotech and AI regain their presence in value terms? June was clearly driven by mega-deals. But will the same scene repeat next month? The answer will come from which industries close the deals currently sitting in review and negotiation first.

※ This report is based on publicly available news and uses data structured and aggregated by AI, with similar-deal duplicates removed. Some values and classifications are estimates. It should not be used as a direct basis for investment decisions.

Written: June 2026, E. Alexandro